文献速递慢性肾脏病

全谷物摄入与慢性肾功能不全队列研究中的健康结局关联

Association of Intake of Whole Grains with Health Outcomes in the Chronic Renal Insufficiency Cohort Study.
PubMed 文献 · Clin J Am Soc Nephrol · 2024-08-14

本研究分析慢性肾功能不全队列数据,横断面评估全谷物摄入与CKD-MBD生物标志物的关联,前瞻性评估其与心血管事件、肾衰竭和全因死亡的关系。结果显示全谷物摄入与CKD-MBD生物标志物无关,而全谷物相对精制谷物摄入比例较高与较低的心血管疾病、肾衰竭和死亡风险相关,提示限制CKD患者全谷物摄入可能缺乏依据。

要点

  • 全谷物摄入与CKD-MBD生物标志物无关。
  • 全谷物相对精制谷物摄入较高与较低肾衰竭、死亡和心血管疾病风险相关。
  • CKD患者限制全谷物摄入可能缺乏依据。

核心结论

  • 全谷物摄入与CKD-MBD生物标志物无关。
  • 全谷物相对精制谷物摄入较高与较低的心血管疾病、肾衰竭和死亡风险相关。
  • 研究结果对长期限制CKD患者全谷物摄入的做法提出质疑。

研究设计与样本

  • 分析慢性肾功能不全队列研究数据,横断面检查CKD-MBD生物标志物,前瞻性检查健康结局。
  • 横断面分析纳入4067名参与者,前瞻性分析纳入4331名参与者。
  • 主要暴露为报告的全谷物摄入量,以份/天、份/1000千卡和精制谷物份数/全谷物份数分析。

主要发现

  • 粗略评估(份/天)时,全谷物摄入与较高磷摄入和血清磷相关,但按能量分析时无此关联。
  • 精制谷物相对全谷物摄入较高与较高肾衰竭风险相关(模型4:1.01;95%CI 1.00-1.02;P=0.01)。
  • 精制谷物相对全谷物摄入较高与较高全因死亡风险相关(模型4:1.01;95%CI 1.00-1.01;P=0.01)。
  • 精制谷物相对全谷物摄入较高与较高心血管疾病风险相关,但完全调整模型除外。
  • 较高膳食密度与较低死亡率相关,仅在调整人口学和临床因素(包括肾功能)的模型中,进一步调整膳食因素的完全调整模型中不显著。

关键数值与推荐

  • CKD-MBD生物标志物包括血清磷、成纤维细胞生长因子-23、甲状旁腺激素、骨化三醇和钙。
  • 结局包括心血管事件、肾衰竭和全因死亡。

临床怎么用

  • CKD患者限制全谷物摄入以管理CKD-MBD可能缺乏依据。
  • 鼓励CKD患者选择全谷物而非精制谷物可能有助于降低心血管疾病、肾衰竭和死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Intake of whole grains was not associated with CKD mineral and bone disorder biomarkers. Intake of whole grains in relation to refined grains was associated with lower risk of cardiovascular disease, kidney failure, and mortality. The restriction of whole grains among people with CKD may be unwarranted. BACKGROUND: Patients with CKD are encouraged to choose refined grains instead of whole grains as part of the low-phosphorus diet for managing CKD-mineral and bone disorders (CKD-MBD). However, there is no direct evidence indicating that limiting whole grains has a beneficial impact on CKD outcomes. METHODS: This study analyzed Chronic Renal Insufficiency Cohort data in two ways, namely cross-sectional examination of CKD-MBD biomarkers and prospective examination of health outcomes. A total of 4067 (cross-sectional) and 4331 (prospective) participants were included. The primary exposure was reported intake of whole grains (analyzed as servings/d, servings/1,000 kcal, and refined grain servings/whole grain servings). CKD-MBD biomarkers included serum phosphorus, fibroblast growth factor-23, parathyroid hormone, calcitriol, and calcium. Outcomes included cardiovascular events, kidney failure, and all-cause mortality. RESULTS: In adjusted models, reported intake of whole grains was associated with higher phosphorus intake and serum phosphorus when assessed crudely (serving/d), but not when analyzed in relation to energy. Higher intake of refined grain relative to whole grains was associated (all models) with higher risk of kidney failure (model 4: 1.01; 95% confidence interval, 1.00 to 1.02; P = 0.01, all-cause mortality (model 4: 1.01; 95% confidence interval, 1.00 to 1.01; P = 0.01), and cardiovascular disease except for the fully adjusted model. Higher dietary density was associated with lower mortality in models adjusted for demographic and clinical factors including kidney function, but not in the fully adjusted model that further adjusted for dietary factors. CONCLUSIONS: Intake of whole grains was not associated with CKD-MBD biomarkers. Intake of whole grains in relation to refined grains was associated with lower risk of cardiovascular disease, kidney failure, and mortality. The results of this study put into question the long-standing practice of restricting whole grains in patients with CKD.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Winkelman D, Smith-Gagen J, Rebholz CM, et al. Association of Intake of Whole Grains with Health Outcomes in the Chronic Renal Insufficiency Cohort Study. Clin J Am Soc Nephrol. 2024. PMID: 39141429. doi:10.2215/CJN.0000000000000538

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。